This national clinical trial aims to identify treatments that may be beneficial for people discharged from hospital after recovering from COVID-19.


Emerging data suggest that around 1 in 10 patients with COVID-19 die and more than 1 in 5 develop new or worsened symptoms during the first three months after discharge from hospital. HEAL-COVID is a clinical trial to compare different treatments to determine whether they can improve the longer-term outcomes for patients who have been hospitalised due to COVID-19. HEAL-COVID has been determined by NIHR to be an Urgent Public Health clinical trial of national importance.

Study metrics



Sites Open


Our latest tweets

View all


NIHR - National Institute for Health Research logo
Cambridge Biodmedical Research Centre
Cambridge Heart and Lung Research Institute
University of Liverpool
LCTC - Liverpool Clinical Trials Centre
University of Cambridge